Media Hub

30
Sep 2019

CHADWICK LAWRENCE APPOINT TWO NEW STAFF MEMBERS TO THE WILLS & PROBATE DEPARTMENT

Following another successful year, Chadwick Lawrence, have recently made two new appointments. The appointments come as the firm look to develop the talent internally and continue to strengthen their Wills & Probate service offering. Ellie Hirst has joined Yorkshires Legal People as a Paralegal and Rochelle Newson, who is now a qualified Solicitor, will both…

Read More

27
Sep 2019

Prostate cancer risk linked to male fertility treatment

A recent study has suggested that men who have fertility treatment carry an increased risk of prostate cancer later in life. The research looked at 1.2 million pregnancies over the course of 20 years and found that men who had received ICSI, a male fertility treatment, had an increased risk of developing prostate cancer. Professor…

Read More

27
Sep 2019

New pancreatic cancer urine test could boost survival rates to 60%

Researchers have predicted that a pioneering new urine test for detecting pancreatic cancer could drastically improve survival rates, following a 90 per cent accuracy rate in recent studies. Pancreatic cancer currently has the lowest survival rate, with only around five per cent of patients still alive five years following diagnosis. The new test, which has…

Read More

27
Sep 2019

Mothers who have had C-section may face greater risk of complications through natural birth

A study by academics at Oxford University suggests mothers are safer choosing to have a C-section for their next delivery, as a vaginal birth increases the risk of a uterine rupture by seven times, and also carries increased risks of blood transfusion, surgical injury and sepsis. Research for the study looked into over 74,000 deliveries…

Read More

27
Sep 2019

Heart transplant waiting list doubles in a decade

Official figures from NHS Blood and Transplant (NHSBT) have revealed that the waiting list for heart transplants has more than doubled in ten years. 313 patients are currently waiting for an organ to become free, a rise of 130 per cent from a decade ago, which is thought to have been caused by an ageing…

Read More

27
Sep 2019

‘Revolutionary’ new tumour-agnostic cancer drugs approved for use

A ‘revolutionary’ new cancer drug which is able to treat a wide range of tumours has been approved for the first time for use across Europe. The new tumour-agnostic drugs target any tumours within the body that have a specific genetic abnormality inside, regardless of where the cancer is growing in the body. UK doctors…

Read More